Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 3
1948 5
1949 2
1951 1
1952 1
1953 1
1954 1
1955 2
1956 3
1957 6
1958 2
1959 1
1960 1
1961 3
1962 3
1963 4
1964 5
1965 1
1968 1
1969 2
1970 9
1971 11
1972 7
1973 10
1974 12
1975 11
1976 10
1977 18
1978 32
1979 22
1980 18
1981 15
1982 22
1983 27
1984 27
1985 22
1986 24
1987 25
1988 25
1989 34
1990 41
1991 45
1992 38
1993 40
1994 51
1995 62
1996 51
1997 58
1998 66
1999 107
2000 136
2001 181
2002 168
2003 167
2004 173
2005 217
2006 228
2007 272
2008 202
2009 194
2010 187
2011 238
2012 250
2013 290
2014 253
2015 314
2016 289
2017 250
2018 282
2019 295
2020 259
2021 252
2022 226
2023 210
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

6,121 results

Results by year

Filters applied: . Clear all
Page 1
Bexsero® chronicle.
Vernikos G, Medini D. Vernikos G, et al. Pathog Glob Health. 2014 Oct;108(7):305-16. doi: 10.1179/2047773214Y.0000000162. Pathog Glob Health. 2014. PMID: 25417906 Free PMC article. Review.
A new roadmap for meningitis.
The Lancet. The Lancet. Lancet. 2020 Apr 18;395(10232):1230. doi: 10.1016/S0140-6736(20)30865-5. Lancet. 2020. PMID: 32305081 No abstract available.
[Vaccinations].
Derancourt C, Spenatto N, Vernay-Vaïsse C, Timsit FJ, Fouéré S, Janier M; la section MST de la SFD. Derancourt C, et al. Ann Dermatol Venereol. 2016 Nov;143(11):782-785. doi: 10.1016/j.annder.2016.09.025. Epub 2016 Oct 21. Ann Dermatol Venereol. 2016. PMID: 27776815 French. No abstract available.
Use of MenACWY-CRM in adolescents in the United States.
Black S, Block SL. Black S, et al. J Adolesc Health. 2013 Mar;52(3):271-7. doi: 10.1016/j.jadohealth.2012.07.017. Epub 2012 Sep 25. J Adolesc Health. 2013. PMID: 23299001 Review.
Adolescents constitute a high-risk group for invasive meningococcal disease. MenACWY-CRM (Menveo, Novartis Vaccines, Cambridge, MA) is a quadrivalent meningococcal conjugate vaccine indicated to prevent invasive meningococcal disease caused by Neisseri …
Adolescents constitute a high-risk group for invasive meningococcal disease. MenACWY-CRM (Menveo, Novartis Vaccines, Cambridge …
Letter from the editor.
Ellis RW, Riedmann EM. Ellis RW, et al. Hum Vaccin Immunother. 2012 Jul;8(7):845. doi: 10.4161/hv.21441. Epub 2012 Jul 1. Hum Vaccin Immunother. 2012. PMID: 22832258 Free article. No abstract available.
Meningococcal Group B Vaccine (4CMenB) in Children.
López-Lacort M, Muñoz-Quiles C, Orrico-Sánchez A. López-Lacort M, et al. N Engl J Med. 2023 Jun 1;388(22):2109. doi: 10.1056/NEJMc2303518. N Engl J Med. 2023. PMID: 37256991 No abstract available.
Meningococcal conjugate vaccines.
Zimmer SM, Stephens DS. Zimmer SM, et al. Expert Opin Pharmacother. 2004 Apr;5(4):855-63. doi: 10.1517/14656566.5.4.855. Expert Opin Pharmacother. 2004. PMID: 15102568 Review.
However, the polysaccharide meningococcal vaccines (i.e., A and C; A, C and W-135; or A, C, Y and W-135) initially developed in the 1970s are generally poorly immunogenic in children or require repeated doses and do not produce long-lasting immunity. ...The search f …
However, the polysaccharide meningococcal vaccines (i.e., A and C; A, C and W-135; or A, C, Y and W-135) initially developed i …
Meningococcal vaccines.
Price AA. Price AA. Curr Pharm Des. 2007;13(19):2009-14. doi: 10.2174/138161207781039850. Curr Pharm Des. 2007. PMID: 17627534 Review.
Without the development of a vaccine against serogroup B, it will be difficult to effectively prevent global meningococcal disease. This review provides a background on N. meningitidis biology and focuses on the current status of meningococcal research and vaccine d …
Without the development of a vaccine against serogroup B, it will be difficult to effectively prevent global meningococcal disease. T …
[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].
Chinese Preventive Medicine Association. Chinese Preventive Medicine Association. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):146-152. doi: 10.3760/cma.j.issn.0253-9624.2019.02.005. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 30744287 Review. Chinese.
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine containing meningococcal polysaccharide conjugate vaccine. This article reviews res
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysac
6,121 results